Dr. Young I. Cho, PhD, is one of the most renowned bioengineering experts in the field of hemorheology, has joined Rheologics Technologies as a member of the company's Board of Advisors. Dr. Cho will be working closely with the company's management team to assist in the advancement of the Rheolog(TM). Dr. Cho also serves as a Professor of Mechanical Engineering & Mechanics at Drexel University in Philadelphia where he was recognized as Researcher of the Year in 1995.
Prior to joining Drexel, Young spent four years at NASA's Jet Propulsion Laboratory at the California Institute of Technology in Pasadena, as a member of the Technical Staff where he led investigations in the fields of human blood viscometry, fluid dynamics, heat transfer, acoustics and energy. For this work he received two NASA Space Act Tech Brief Awards.
He served as one of the United States delegates to the US-Korea Heat Transfer Conference and Fluid Flow Conference both sponsored by NSF held in Seoul, Korea. He was the recipient of the Lindback Award for excellence in teaching at Drexel University in 1992. In 1993, Dr. Cho was nominated by the United States of America's Department Of Energy (DOE) and elected as the chairman of the Advanced Fluid Committee under the International Energy Agency.
Dr. Cho has authored/co-authored numerous papers in the areas of heat transfer, fluid mechanics, rheology, aerodynamics, acoustics, combustion and energy. He is a reviewer for ASME Applied Mechanics Reviews, J. of Heat Transfer, International Journal of the Heat and Mass Transfer, AIChE Journal, J. of Biomechanics, J of Biomechanical Eng., AIAA, and Chemical Engineering Communications. He is an editor for Handbook of Heat Transfer (McGraw Hill, 3rd ed.) and an associate editor for the Advances in Heat Transfer (Academic Press).
He has been cited in Who's Who in the East, Who's Who in American Education, Who's Who in Science and Engineering, Who's Who in the Emerging Leaders in the World, Who's Who in America, and Who's Who in the World.
Dr. Cho will officially serve as the company's Co-Chief Scientific Advisor with Kenneth R. Kensey, MD, originator of Rheologics, Inc. Dr. Cho stated, "I would like to thank Rheologics for giving me the opportunity to lend my assistance. The Company's technology is very exciting and has incredible potential to help diagnose and treat vascular diseases long before they become symptomatic. I am looking forward to working with the other team members to move Rheologics ahead."
Alfonso Knoll, President of Rheologics Technologies, said, "We are thrilled to have Dr. Young Cho join our team. His long legacy in the field of bioengineering, especially his extensive work in the area of fluid dynamics, will serve the Company tremendously. He is recognized by his peers as one of the top thought-leaders in his field. We are truly honored to have him on board."
To learn more about Rheologics please visit www.rehologics.com.
Safe Harbor for Forward-Looking Statements: Except for historical information contained herein, the statements in this Press Release are forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Reform Act of 1995. Forward-looking statements involve known and unknown risks and uncertainties, which may cause the Company's actual results in the future periods to differ materially from forecasted results. These risks and uncertainties include, among other things, product price volatility, product demand, market competition, risk inherent in the Company's operations, imprecision in estimating product reserves and the Company's ability to replace and expand its real estate interests. Rheologics Technologies Inc. assumes no obligation to update the information contained in this press release, whether as a result of new information, future events or otherwise.